ストックスクリーナーアプリを入手
3.175
5.22%
-0.175
Allurion Technologies Inc (ALUR) 最新ニュース
Allurion Technologies CEO Gaur Shantanu acquires $26,800 in stock By Investing.com - Investing.com Canada
Allurion Technologies CEO Gaur Shantanu acquires $26,800 in stock - Investing.com India
Allurion Technologies CEO Acquires 8,000 Shares - TradingView
12 Consumer Discretionary Stocks Moving In Monday's After-Market Session - Benzinga
Allurion Technologies’ Earnings Call: Growth Amid Challenges - TipRanks
Chardan holds Allurion stock at Neutral with a $2.50 target By Investing.com - Investing.com South Africa
Chardan holds Allurion stock at Neutral with a $2.50 target - Investing.com
Allurion Technologies Inc (ALUR) Q4 2024 Earnings Call Highlights: Strategic Restructuring and ... By GuruFocus - Investing.com Canada
Allurion Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update - BioSpace
TD Cowen Cuts Allurion Technologies' Price Target to $6 From $16, Buy Rating Maintained - MarketScreener
Allurion Technologies, Inc. (ALUR) Reports Q4 Loss, Lags Revenue Estimates - MSN
Earnings call transcript: Allurion Technologies’ Q4 2024 shows revenue drop, strategic shifts By Investing.com - Investing.com South Africa
Earnings call transcript: Allurion Technologies’ Q4 2024 shows revenue drop, strategic shifts - Investing.com
Allurion Technologies Inc reports results for the quarter ended December 31Earnings Summary - TradingView
ALLURION TECHNOLOGIES Earnings Results: $ALUR Reports Quarterly Earnings - Nasdaq
Earnings Scheduled For March 26, 2025 - Benzinga
Allurion Technologies Reports 2024 Financial Results and Outlook - TipRanks
What To Expect From Allurion Technologies Inc (ALUR) Q4 2024 Earnings - Yahoo Finance
Allurion surges on weight loss data from gastric balloon, GLP-1 combo treatment - MSN
Gold Down Over 1%; Micron Technology Shares Fall After Q2 Earnings - Benzinga
Allurion Stock Soars on Promising GLP-1 Combo Results - Wall Street Pit
Promising Potential of Allurion Technologies’ Innovative Approach Supports Buy Rating - TipRanks
Why Ouster Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga
US Stocks Likely To Open Lower, But 'Economic Conditions Don't Signal A Downturn,' Say Analysts As They Expect 'Resilient Earnings' To Lift EquitiesAllurion Technologies (NYSE:ALUR), Accenture (NYSE:ACN) - Benzinga
Allurion reports weight loss and muscle gain with new therapy By Investing.com - Investing.com South Africa
Allurion Technologies Reports Positive Ballon Combination Study Results; Shares Jump - MarketScreener
Allurion Announces Initial Results on the Combination of the Allurion Program With Low-dose GLP-1 Therapy to Optimize Muscle Mass and GLP-1 Adherence - BioSpace
12 Consumer Discretionary Stocks Moving In Thursday's After-Market Session - Benzinga
Allurion reports weight loss and muscle gain with new therapy - Investing.com India
Revolutionary Weight Loss Results: Allurion Balloon Plus Low-Dose GLP-1 Shows 20% Weight Loss, Preserves Muscle - StockTitan
Analysts Offer Insights on Healthcare Companies: Allurion Technologies (ALUR) and Esperion (ESPR) - The Globe and Mail
ALLURION TECHNOLOGIES Earnings Preview: Recent $ALUR Insider Trading, Hedge Fund Activity, and More - Nasdaq
Allurion’s Next-Generation Weight Loss Device Earns New Patents - MPO-mag
Allurion Technologies (ALUR) Projected to Post Quarterly Earnings on Thursday - Defense World
Allurion to Report Fourth Quarter 2024 Financial Results on March 26, 2025 - The Joplin Globe
Q1 EPS Forecast for Allurion Technologies Cut by Analyst - Defense World
Allurion Technologies price target lowered to $16 on split-adjusted basis - TipRanks
Allurion Balloon Reintroduced in France - MPO-mag
Allurion Announces Notification of Issuance of New U.S. Patents on Next-Generation Weight Loss Device for the Treatment of Obesity - BioSpace
Allurion Technologies announces issuance of new patents on weight loss device - TipRanks
Allurion Announces Notification Of Issuance Of New U.S. Patents On Next-Generation Weight Loss Device For The Treatment Of Obesity - Marketscreener.com
Allurion to Participate in Upcoming Investor Conferences - 01Net
Allurion to Participate in Upcoming Investor Conferences -February 25, 2025 at 04:06 pm EST - Marketscreener.com
Can Allurion's Anti-Obesity Strategy Impress Investors at Major Healthcare Conferences? - StockTitan
ALURALLURION TECHNOLOGIES INC Latest Stock News & Market Updates - StockTitan
Allurion to raise $6.1 million in direct offering and private placement - MSN
Allurion Announces Closing of Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline - BioSpace
Can Allurion's Balloon-GLP-1 Combo Reshape Weight Loss Treatment? $6.1M Bet Says Yes - StockTitan
Allurion announces $6.1 million stock and warrant sale By Investing.com - Investing.com South Africa
Allurion announces $6.1 million stock and warrant sale - Investing.com
Allurion Tech dips on $6.1 million stock offering - TradingView
S&P 500 Edges Higher; Analog Devices Earnings Top Views - Benzinga
Stock market news: Allurion Technologies -31.00%, Bumble -28.09% among biggest losers during midday trading - Business Upturn
Allurion Technologies Expects to Raise $6.1 Million From Stock Offering; Shares Plunge - Marketscreener.com
Dow Dips 150 Points; US Housing Starts Fall In January - Benzinga
Allurion to sell 900,000 shares at $5.23 in registered direct offering - TipRanks
0.62%
0.92%
大文字化:
|
ボリューム (24 時間):